Catalio Capital Management, LP Q2 2025 Filing
Filed August 14, 2025
Portfolio Value
$476.9B
Holdings
40
Report Date
Q2 2025
Filing Type
13F-HR
All Holdings (40 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | LLYELI LILLY & CO | 53,916 | $42.0B | 8.81% | |
| 2 | BBIOBRIDGEBIO PHARMA INC | 927,711 | $40.1B | 8.40% | |
| 3 | SLNOSOLENO THERAPEUTICS INC | 409,944 | $34.3B | 7.20% | |
| 4 | ASNDASCENDIS PHARMA A/S | 179,926 | $31.1B | 6.51% | |
| 5 | ISRGINTUITIVE SURGICAL INC | 56,674 | $30.8B | 6.46% | |
| 6 | EWEDWARDS LIFESCIENCES CORP | 390,932 | $30.6B | 6.41% | |
| 7 | GILDGILEAD SCIENCES INC | 226,875 | $25.2B | 5.27% | |
| 8 | BSXBOSTON SCIENTIFIC CORP | 229,046 | $24.6B | 5.16% | |
| 9 | CYTKCYTOKINETICS INC | 601,439 | $19.9B | 4.17% | |
| 10 | SNDXSYNDAX PHARMACEUTICALS INC | 2,104,512 | $19.7B | 4.13% | |
| 11 | TEVATEVA PHARMACEUTICAL INDS LTD | 1,170,372 | $19.6B | 4.11% | |
| 12 | HTDCORCEPT THERAPEUTICS INC | 239,125 | $17.6B | 3.68% | |
| 13 | NTRANATERA INC | 97,297 | $16.4B | 3.45% | |
| 14 | ADPTADAPTIVE BIOTECHNOLOGIES COR | 1,396,445 | $16.3B | 3.41% | |
| 15 | DNTHDIANTHUS THERAPEUTICS INC | 746,527 | $13.9B | 2.92% | |
| 16 | GPCRSTRUCTURE THERAPEUTICS INC | 670,575 | $13.9B | 2.92% | |
| 17 | ADMAADMA BIOLOGICS INC | 569,704 | $10.4B | 2.18% | |
| 18 | HALOHALOZYME THERAPEUTICS INC | 191,529 | $10.0B | 2.09% | |
| 19 | RAREULTRAGENYX PHARMACEUTICAL IN | 213,402 | $7.8B | 1.63% | |
| 20 | MLTXMOONLAKE IMMUNOTHERAPEUTICS | 162,596 | $7.7B | 1.61% | |
| 21 | PHATPHATHOM PHARMACEUTICALS INC | 672,290 | $6.4B | 1.35% | |
| 22 | QUREUNIQURE NV | 417,443 | $5.8B | 1.22% | |
| 23 | WGSGENEDX HOLDINGS CORP | 61,507 | $5.7B | 1.19% | |
| 24 | TARAPROTARA THERAPEUTICS INC | 1,626,370 | $4.9B | 1.03% | |
| 25 | OMOUTSET MED INC | 166,666 | $3.2B | 0.67% | |
| 26 | SEPNSEPTERNA INC | 294,360 | $3.1B | 0.65% | |
| 27 | REPLREPLIMUNE GROUP INC | 330,337 | $3.1B | 0.64% | |
| 28 | ZBIOZENAS BIOPHARMA INC | 215,314 | $2.1B | 0.44% | |
| 29 | VIRVIR BIOTECHNOLOGY INC | 388,303 | $2.0B | 0.41% | |
| 30 | KYTXKYVERNA THERAPEUTICS INC | 586,909 | $1.8B | 0.38% | |
| 31 | IRONDISC MEDICINE INC | 30,661 | $1.6B | 0.34% | |
| 32 | FULCFULCRUM THERAPEUTICS INC | 188,304 | $1.3B | 0.27% | |
| 33 | BCAXBICARA THERAPEUTICS INC | 97,800 | $908.6M | 0.19% | |
| 34 | MGXMETAGENOMI INC | 528,993 | $782.9M | 0.16% | |
| 35 | KPTIKARYOPHARM THERAPEUTICS INC | 146,013 | $629.3M | 0.13% | |
| 36 | HYPRHYPERFINE INC | 760,035 | $546.9M | 0.11% | |
| 37 | —MERSANA THERAPEUTICS INC | 1,567,413 | $464.0M | 0.10% | |
| 38 | ATAIATAI LIFE SCIENCES NV | 196,858 | $431.1M | 0.09% | |
| 39 | GUTSFRACTYL HEALTH INC | 214,236 | $347.1M | 0.07% | |
| 40 | SNSESENSEI BIOTHERAPEUTICS INC | 14,718 | $126.3M | 0.03% |